¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"substance dependence disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • extrapyramidal disorder
    ÇǶó¹Ìµå¹Ù±ù±æÀå¾Ö, Ãßü¿Ü·ÎÀå¾Ö
  • eating disorder
    ½Ä»çÀå¾Ö
  • female sexual arousal disorder
    ¿©¼º¼º(Àû)ÈïºÐÀå¾Ö
  • factitious disorder
    ÀÎÀ§Àå¾Ö
  • functional disorder
    ±â´É¼ºÀå¾Ö
  • gender identity disorder
    ¼ºÁ¤Ã¼¼ºÀå¾Ö
  • generalized anxiety disorder
    ¹üºÒ¾ÈÀå¾Ö
  • genetic disorder
    À¯ÀüÁúȯ
  • hyperkinetic disorder
    ¿îµ¿°ú´ÙÀå¾Ö, ¿îµ¿°ú´ÙÁúȯ
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypoactive sexual desire disorder
    ¼º¿å°¨¼Òº´
  • hearing disorder
    µè±âÀå¾Ö, û·ÂÀå¾Ö
  • hematologic disorder
    Ç÷¾×Àå¾Ö
  • hemostatic disorder
    ÁöÇ÷Àå¾Ö, Ç÷¾×ÀÀ°íÀå¾Ö
  • hereditary coagulation disorder
    À¯ÀüÀÀ°íÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ÀÔ¼Ò¸®Àå¾Ö, ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀΰÝÀå¾Ö
  • auditory disorder
    û·ÂÀå¾Ö, ³­Ã»
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
  • autosomal recessive disorder
    º¸Åë¿°»öü¿­¼ºÁúȯ
  • avoidant personality disorder
    ȸÇÇÀΰÝÀå¾Ö
  • behavior disorder
    ÇൿÀå¾Ö
  • borderline personality disorder
    °æ°èÀΰÝÀå¾Ö, ÁØÀΰÝÀå¾Ö
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • chromosomal disorder
    ¿°»öüÀå¾Ö
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • circadian rhythm sleep disorder
    ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÇÏ·çÁÖ±â¼ö¸éÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • impulse disorder
    Ãæµ¿ Àå¾Ö, Ãæµ¿º´
  • impulse disorder, hyperkinetic
    °úÀ׿¼º Ãæµ¿Àå¾Ö
  • impulse disorder, hyperkinetic
    °ú¿îµ¿¼º Ãæµ¿Àå¾Ö.
  • impulse-control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö
  • induced delusional disorder
    À¯¹ß¼º ¸Á»óÀå¾Ö, ~¸Á»óº´
  • persistent somatoform pain disorder
    Áö¼Ó¼º ½ÅüÇü µ¿ÅëÀå¾Ö(º´)
  • personality disorder
    ÀΰÝÀå¾Ö(¡­î¡äô).
  • personality disorder, amoral
    ºñµµ´öÀû ÀΰÝÀå¾Ö
  • personality disorder, anankastic
    °­¹Ú¼º(Ë­ÚÞàõ) ÀΰÝÀå¾Ö
  • personality disorder, antisocial
    ¹Ý»çȸ¼º(ÚãÞäüåàõ) ÀΰÝÀå¾Ö
  • personality disorder, anxious
    ºÒ¾È¼º ÀΰÝÀå¾Ö
  • personality disorder, asocial
    ºñ»çȸ¼º ÀΰÝÀå¾Ö
  • personality disorder, asthenic
    ¹«·ÂÁõÀû(ÙíÕôñøîÜ) ÀΰÝÀå¾Ö
  • personality disorder, avoidant
    ȸÇǼº(üÞù­àõ) ÀΰÝÀå¾Ö
  • personality disorder, borderline
    °æ°è¼º(ÌÑÍ£àõ) ÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • neurotransmitter =nerve transmitter substance
    ½Å°æÀü´Þ¹°Áú.
  • neurotransmitter [=nerve transmitter substance]
    ½Å°æÀü´Þ¹°Áú
  • odoriferous substance
    Çâ·á(úÅè÷).
  • osteoid substance
    Dz»À¹°Áú
  • oxytocic substance
    ÀڱüöÃ༺ ¹°Áú.
  • pain producing substance =PPS
    µ¿Åë À¯¹ß¹°Áú.
  • paramagnetic substance
    »óÀÚ¼º ¹°Áú
  • periaqueductal gray substance
    ¼öµµ°üÁÖÀ§È¸»öÁú
  • pneumococcal C-substance
    Æó·Å±¸±Õ C-¹°Áú
  • postacrosomal substance
    ÷´ÜüµÚ¹°Áú
  • posterior perforated substance
    µÚ°üÅëÁú
  • posterior perforated substance ³ª substantia perforata posterior
    ÈÄÀ¯°øÁú(ý­êóÍîòõ).
  • posterior perforated substance ³ª substantia perforata posterior
    ÈÄÀ¯°øÁú(ý­êóÍîòõ).
  • pressor substance
    Ç÷¾Ð»ó½Â¹°Áú(¡­Úªòõ).
  • proper substance of cornea
    °¢¸·°íÀ¯Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
EPS ear-patella-short stature [syndrome]; elastosis perforans serpiginosa; electrophysiologic study; enz...
ESS empty sella syndrome; endostreptosin; erythrocyte-sensitizing substance; euthyroid sick syndrome; ev...
E-sub excitor substance
FMS fat-mobilizing substance; Fellow of the Medical Society; fibromyalgia syndrome; full mouth series
FRS Fellow of the Royal Society; ferredoxin-reducing substance; first rank symptom; furosemide
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
SUD Substance Use Disorders
TBARS TBA reactive substance
TSCA Toxic Substance Control Act
SPI substance P-like immunoreactive
SICRI substance immunologically cross reactive with insulin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • induced psychotic disorder
    À¯µµµÈ Á¤½Åº´Àû Àå¾Ö
    ÇöÀúÇÑ ¸Á»óÀ¸·Î ÀÌ¹Ì Á¤½Åº´Àû Àå¾Ö¸¦ °¡Áø ¾î¶² »ç¶÷°ú Ä£±ÙÇÑ °ü°è¸¦ °¡Áø °á°ú·Î, ´ÙÀ½ »ç¶÷¿¡°Ôµµ »ý±ä ¸Á»óü°è.
  • inflammatory disorder
    ¿°Áõ¼º Àå¾Ö
  • inflammatory joint disorder
    ¿°Áõ¼º °üÀý Àå¾Ö
  • intermittent explosive disorder
    °£ÇæÀû Æø¹ß¼º Àå¾Ö
    °£ÇæÀûÀ¸·Î ¿©·¯ ¹ø °ø°Ý¼º Ãæµ¿ÀÇ Á¶Á¤À» »ó½ÇÇÏ¿© ±× »ç¶÷ÀÇ Á¤»óÀû Àΰݿ¡ ¸ÂÁö ¾Ê´Â ½ÉÇÑ ÆøÇàÀ̳ª ±â¹° ÆÄ±«¸¦ ÃÊ·¡ÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÎ ±â´ÉÀû Á¤½Å Àå¾ÖÀÇ ÀÏÁ¾. Àü¿¡´Â Æø¹ß¼º ÀÎ°Ý ¶Ç´Â °£ÁúÇü ÀÎ°Ý Àå¾Ö¶ó°í ĪÇߴµ¥, °£ÇæÀû ÇൿÀÌ ÀÎ°Ý Æ¯¼ºÀÌ µÉ ¼ö ¾øÀ¸¹Ç·Î À߸øµÈ ȣĪÀÌ´Ù.
  • intracapsular disorder
    °üÀý³¶³» Àå¾Ö
  • joint disorder
    °üÀý Àå¾Ö
  • language disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
  • late luteal phase dysphoric disorder
    ¸»±â Ȳü±â ºÒÄè Àå¾Ö
  • major depressive disorder
    ÁÖ¿ä ¿ì¿ïÁõ
  • masticatory muscle pain disorder
    ÀúÀÛ±Ù µ¿Åë Àå¾Ö
  • menopausal disorder
    °»³â±â Àå¾Ö
    °»³â±â¿¡ »ý±â´Â ÀÚÀ²½Å°æ ½ÇÁ¶Áõ. ³­¼ÒÀÇ ³»ºÐºñ ±â´ÉÀÇ °¨Å𳪠ÆóÀýÀÌ ÁÖµÈ ¿øÀÎÀ̸ç, ¶ÇÇÑ °¢Á¾ÀÇ ³»ºÐºñ¼±, ƯÈ÷ ³úÇϼöü Àü¿±, °©»ó¼±, ºÎ½Å ¶Ç´Â ÃéÀå µîÀÇ ±â´ÉÀå¾Ö·Î ±×µé »óÈ£°£ÀÇ ÆòÇü ½ÇÁ¶¸¦ °¡Á®¿À°í, ³¡³»´Â ³»ºÐºñ Àå±â¸¦ Áö¹èÇÏ´Â ÀÚÀ²½Å°æ °èÅë¿¡ ¿µÇâÀ» ³¢ÃÄ ±³°¨½Å°æ ¶Ç´Â ºÎ±³°¨½Å°æ¿¡ ±äÀåÀ» ÃÊ·¡Çϱ⠶§¹®À̶ó°í ¿©°ÜÁö°í ÀÖ´Ù. Áõ¼¼¿¡´Â ±¹ºÎÀû Áõ¼¼¿Í Àü½Å Áõ¼¼°¡ ÀÖ´Ù. ±¹ºÎÀûÀÎ Áõ¼¼·Î´Â ³»¿Ü ¼º±âÀÇ À§ÃàÀÌ ÁÖµÈ Áõ»óÀÌ´Ù. ¿Ü¼º±âÀÎ ´ë, ¼ÒÀ½¼øÀº Áö¹æÀÇ ¼Ò½Ç·Î À§ÃàµÇ°í, À½¸ð´Â ¹«»öÀÌ µÈ´Ù. ³»¼º±â¿¡¼­´Â Áú º®ÀÌ ÆòÆòÇØÁö°í Áú °­Àº Á¼¾ÆÁö´Âµ¥, ¶§·Î´Â Áú¿° ¶§¹®¿¡ Áú °­ÀÌ À¯ÂøµÈ´Ù. ÀÚ±ÃÀº ±Ù¼¶À¯ÀÇ À§ÃàÀ¸·Î ÀüüÀûÀ¸·Î Âɱ׶óµé¸ç, °æ°ü ¹× ³» Àڱà ±¸´Â ¸Å¿ì Á¼¾ÆÁ®¼­ ¶§·Î´Â Æó¼âµÇ¾î À¯¼öÁ¾ ¶Ç´Â À¯³óÁ¾ÀÌ »ý±æ ¶§µµ ÀÖ´Ù. ³­¼Ò´Â ÀÛ¾ÆÁö°í ±â´Éµµ °¨ÅðÇÏ¿© ƯÀ¯ÀÇ ³­¼Ò ÁÖ±âÀÇ ºÒ±ÔĢȭ¿¡ µû¶ó ¿ù°æ ºÒ¼øÀ» ÀÏÀ¸Å°¸ç ¿ÏÀü Æó°æ¿¡ À̸¥´Ù. ³­°ü, Àڱà Àδë, º¹¸· µîµµ À§ÃàÇÑ´Ù. Á¦2Â÷ ¼ºÂ¡À¸·Î À¯¹æ°ú Àü½Å¿¡ °ÉÃÄ ÇÇÇÏ Áö¹æ Á¶Á÷ÀÇ ¼Ò½ÇÀÌ ÀϾ ¿©¼º´Ù¿î ¸ö¸Å¸¦ ÀÒ°Ô µÇ°í, ½ÉÁö¾î´Â ÀÔ°¡¿¡ ¼ö¿°ÀÌ ³ª´Â µî ³²¼ºÀûÀ¸·Î º¯¸ðÇÏ´Â °æ¿ìµµ ÀÖ´Ù. Àü½ÅÀÇ Áõ¼¼·Î´Â Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö¿Í ÀÚÀ²½Å°æÁõÀÎ ¿­°¨, ³ÃÁõ, ÈïºÐ°¨, ½É°è Ç×Áø, ºÎÁ¤¸Æ, ºÎÁ¾ µîÀÌ ÀÖ´Ù. Á¤½Å ½Å°æ Àå¾Ö·Î´Â µÎÅë, µÎÁß°¨, Çö±âÁõ, ºÒ¸éÁõ, À̸íÁõ, ¿ì¿ïÁõ
  • metabolism disorder
    ´ë»ç Àå¾Ö
  • monopolar disorder
    ´Ü±Ø¼º Àå¾Ö
  • mood disorder
    ±âºÐ Àå¾Ö
  • motor output disorder
    ¿îµ¿¼º Ãâ·Â Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
major mood disorder See: bipolar disorder, affective psychosis, endogenous depression, dysthymia.
(05 Mar 2000)
panic disorder Symptoms of panic attack usually begin abruptly and include rapid heartbeat, chest sensations, shortness of breath, dizziness, tingling, and anxiousness. Treatments include several medications and psychotherapy.
(12 Dec 1998)
Gaucher disorder <disease> A chronic congenital disease of lipid metabolism caused by a deficiency of the beta-glucocerebrosidase enzyme. The defect is most common in Ashkenazi Jews. Clinical features are hepatosplenomegaly (enlargement of liver and spleen) and in severe early onset forms of the disease, with neurological dysfunction.
Inheritance: autosomal recessive.
(27 Sep 1997)
gene disorder Hereditary disorder caused by a mutant allele of a single gene (e.g., Duchenne muscular dystrophy, retinoblastoma, sickle cell disease).
Compare polygenic disorders.
(05 Mar 2000)
manic-depressive disorder An obsolete term for one of the mood disorders; i.e., bipolar disorder, depression; affective psychosis, affective disorder, bipolar disorder, and endogenous depression.
(05 Mar 2000)
generalised anxiety disorder Chronic, repeated episodes of anxiety reactions; a psychological disorder in which anxiety or morbid fear and dread accompanied by autonomic changes are prominent features.
See: anxiety.
(05 Mar 2000)
reactive attachment disorder Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type).
(12 Dec 1998)
paranoid disorder A false belief, seen most often in psychosis (for example schizophrenia).
(27 Sep 1997)
paranoid personality disorder A personality disorder characterised by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity, and mistrust.
(12 Dec 1998)
passive-aggressive personality disorder A personality disorder characterised by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency.
(12 Dec 1998)
visceral disorder Nomenclature used in reference to psychosomatic disorder.
(05 Mar 2000)
REM behaviour disorder A disorder characterised by lack of the atonia of voluntary muscles that normally occurs in REM sleep.
(05 Mar 2000)
memory disorder Disturbances in registering an impression, in the retention of an acquired impression or in the recall of an impression.
(12 Dec 1998)
character disorder A term referring to a group of behavioural disorder's, now replaced by a more general term, personality disorder, of which character disorder's are now a subclass.
(05 Mar 2000)
mental disorder A psychological syndrome or behavioural pattern that is associated with either subjective distress or objective impairment.
See: mental illness, behaviour disorder.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á